The Definitive Guide to Setting Up Life Sciences, Pharmacovigilance and Clinical Data Management Global Capability Centres (GCCs) in Pune, India in 2026-2027

Jai Shri Krishna. Pune is the global capital of Pharmacovigilance and Clinical Data Management Global Capability Centres (GCCs). The combination of a deep BPharm and life sciences graduate pipeline, structurally low attrition, a mature ecosystem of pharma and life sciences captive GCCs (Eli Lilly Capability India, AstraZeneca, Pfizer, Novartis, Sanofi, Bristol-Myers Squibb, MSD, Takeda, Bayer, Boehringer Ingelheim, ICON, IQVIA, Parexel, PPD, Syneos) and lowest fully loaded cost among Tier 1 Indian cities has made Pune the marginal-best city for scaled Life Sciences GCC charters in India and arguably in the world. This pillar guide is the most comprehensive public document on building a Life Sciences GCC in Pune.

1. Executive Summary

• Pune is the city where Eli Lilly's largest non-US capability centre is anchored, where AstraZeneca runs one of its three global Pharmacovigilance hubs, where Novartis, Sanofi, MSD, Pfizer, BMS, Takeda, Bayer and Boehringer Ingelheim have built scaled clinical operations, biostats, programming and PV teams.
• Pune produces approximately 6,500 BPharm and MPharm graduates per year from Bharati Vidyapeeth, Poona College of Pharmacy, Sinhgad, MIT, AISSMS, Modern College and Padmashree Dr DY Patil. Add the deep MSc Life Sciences pool from Savitribai Phule Pune University (SPPU), Symbiosis, MIT WPU and the lateral pool from existing PV captives, and Pune offers India's deepest scaled PV and CDM talent base.
• Fully loaded cost per FTE for a Senior Pharmacovigilance Scientist in Pune is 14 per cent to 20 per cent lower than Mumbai and 8 per cent to 12 per cent lower than Hyderabad. Cost arbitrage versus Basel, Cambridge MA, Princeton, London, Tokyo, Osaka, Sydney is 70 per cent to 80 per cent.
• Voluntary attrition in Pune Life Sciences GCCs ran at 10 per cent to 14 per cent through FY 2026, the lowest among Tier 1 Indian cities for life sciences roles.
• Hinjawadi (Rajiv Gandhi Infotech Park), Kharadi (EON Free Zone, World Trade Centre), Magarpatta City, Viman Nagar, Baner Balewadi and Talegaon collectively offer 70 million plus square feet of Grade A office stock.
• A 400 FTE Pune Life Sciences GCC can be productive within 10 to 13 months of board approval.

2. Why Pune, Specifically for Life Sciences

Three forces explain Pune's Life Sciences dominance. One, the lineage effect. Eli Lilly Capability India was established in Pune in 2016 and seeded a generation of PV, CDM, biostats and clinical operations leaders who have since moved across captives. Two, the BPharm pipeline depth, Maharashtra produces the highest BPharm graduate count in India and Pune is the academic capital. Three, structurally low attrition driven by Pune's livability, climate, lower cost of living and the absence of consumer-internet hyper-attrition that plagues Bangalore.

3. The Life Sciences Talent Engine in Pune

• Bharati Vidyapeeth Deemed University, College of Pharmacy, top 5 pharmacy school in India
• Poona College of Pharmacy, Sinhgad Institute of Pharmacy, AISSMS College of Pharmacy, Modern College of Pharmacy, MIT College of Pharmacy
• Savitribai Phule Pune University (SPPU), deep MSc Life Sciences, MSc Biotechnology, MSc Microbiology and PhD pipeline
• National Centre for Cell Science (NCCS) Pune, Agharkar Research Institute, National Chemical Laboratory (NCL), Indian Institute of Tropical Meteorology, a strong research base
• Symbiosis Institute of Health Sciences, Symbiosis School of Biological Sciences
• BJ Medical College, Armed Forces Medical College (AFMC), DY Patil Medical College, Bharati Hospital, Sancheti, KEM Pune, for the MBBS and MD lateral pool
• Lateral pool of 95,000 plus PV, CDM, biostats, programming, clinical operations, medical writing and regulatory affairs professionals across Eli Lilly, AstraZeneca, Novartis, Sanofi, Pfizer, BMS, MSD, Takeda, Bayer, Boehringer Ingelheim, ICON, IQVIA, Parexel, PPD and Syneos in Pune

4. Micro-Market Map

• Hinjawadi (Rajiv Gandhi Infotech Park Phases 1, 2, 3), INR 75 to INR 110, the IT-ITES core, deep BPharm commute corridor, best for scaled PV and CDM
• Kharadi (EON Free Zone, World Trade Centre Kharadi), INR 90 to INR 135, premium positioning, Pune's east-side hub
• Magarpatta City, INR 80 to INR 120, mature, deep MNC clustering
• Viman Nagar, INR 85 to INR 125, airport proximity, expat-friendly
• Baner Balewadi, INR 80 to INR 115, fast emerging
• Talegaon (off Mumbai-Pune Expressway), INR 50 to INR 80, lowest cost, best for scaled PV CoEs of 500 plus FTEs

5. Compensation Bands for 2026, Pune Life Sciences

• PV Associate (BPharm fresher, ICSR case processing), INR 4.5 to 7.5 lakh per annum
• PV Senior Associate, 2 to 4 years, INR 8 to 13 lakh per annum
• PV Scientist (MPharm / PhD), 4 to 7 years, INR 14 to 24 lakh per annum
• Senior PV Scientist, 7 to 12 years, INR 25 to 42 lakh per annum
• PV Physician (MBBS / MD), INR 32 to 60 lakh per annum
• Clinical Data Manager, 4 to 7 years, INR 12 to 22 lakh per annum
• Senior CDM / Lead Data Manager, INR 22 to 38 lakh per annum
• Biostatistician (MSc / PhD), 4 to 8 years, INR 18 to 35 lakh per annum
• Senior Statistical Programmer (SAS, R, Python), INR 22 to 42 lakh per annum
• Medical Writer (MPharm / PhD / MBBS), INR 14 to 30 lakh per annum
• Senior Medical Writer, INR 30 to 55 lakh per annum

6. Charter Patterns We See in Pune Life Sciences GCCs

• Pharmacovigilance (PV), ICSR case processing, aggregate reports (PSUR, PBRER, DSUR), signal detection, risk management plans (RMP), literature monitoring, medical review
• Clinical Data Management (CDM), study set-up, EDC build, data review, query management, lock readiness on Medidata Rave, Veeva CDMS, Oracle Inform
• Biostatistics and Statistical Programming, SDTM / ADaM, SAS, R, Python, TLF generation
• Medical Writing, clinical study reports (CSR), protocols, investigator brochures, publications
• Clinical Trial Management, study start-up, site management, monitoring oversight, vendor management
• Regulatory Operations, eCTD publishing, submission management
• Real World Evidence (RWE) and epidemiology programming
• Pharmacoepidemiology and outcomes research
• Patient Safety Database operations (Argus, ARISg, Veeva Vault Safety)

7. Regulatory, GxP and Tax Posture

• Companies Act 2013 private limited company
• STPI Pune (Hinjawadi or Kharadi) registration for export of life sciences services
• CBDT safe harbour, 18 per cent cost plus for ITES BPM services up to INR 200 crore
• GST registration in Maharashtra, zero rated export of services with LUT
• ICH-E2E, ICH-E6 (GCP), ICH-E9 (statistics), GVP, FDA 21 CFR Part 11, EU Annex 11, ALCOA+ data integrity
• ISO 27001:2022, SOC 2 Type II, GxP-compliant infrastructure
• DPDP Act 2023 readiness for patient and trial subject data

8. Pune Versus Hyderabad Versus Mumbai Versus Bangalore for Life Sciences

• Pune, best for PV, CDM, biostats, statistical programming, medical writing at scale, lowest cost, lowest attrition
• Hyderabad, best for biostats, clinical data, bulk drug, vaccines, semiconductor-adjacent biotech
• Mumbai, best for regulatory affairs, medical affairs, HEOR, commercial analytics, market access
• Bangalore, best for biotech, AI drug discovery, RWE technology platforms
• Most mature global pharma parents anchor scaled PV / CDM in Pune, regulatory and commercial in Mumbai, and clinical / bulk drug in Hyderabad

9. 30-60-90 Day Launch Plan

• Day 0 to 30, charter sign-off, entity, STPI Pune, GST, FDI, Country Head and Head of PV / CDM appointment
• Day 31 to 60, real estate lease in Hinjawadi or Kharadi, GxP-compliant IT, validation master plan, HR Manual, Payroll, statutory
• Day 61 to 90, first wave of 20 to 40 PV, CDM, biostats and medical writing hires, parent-led GxP knowledge transfer, SOP localisation

10. BOT, Managed GCC and Direct Captive

Pune Life Sciences GCCs are the textbook BOT case. ChirayuGCC stands up the entity, GxP infrastructure, recruits the first 100 to 250 FTEs of PV, CDM, biostats and medical writing under managed model for 24 to 36 months, with transfer at month 24 or 30. This compresses risk and time to throughput by 9 to 12 months versus Direct.

11. GenAI in Life Sciences, Pune-Specific

GenAI is reshaping PV case intake, narrative writing, literature triage, signal detection augmentation, CDM query writing, medical writing first drafts and biostats SAP authoring. A 300 FTE Pune Life Sciences GCC in 2026 ships the throughput of a 480 FTE GCC of 2022 for PV and CDM workflows.

12. GxP, Data Integrity and Cybersecurity

ICH-E2E, ICH-E6, ICH-E9, GVP, FDA 21 CFR Part 11, EU Annex 11, ALCOA+, ISO 27001:2022, SOC 2 Type II, validated systems master list, computer systems validation (CSV) plan are non-negotiable. Head of Quality and CSV Lead in the first 90 days.

13. Cost Modelling, a 400 FTE Pune Life Sciences GCC

• Year 1: 90 FTEs, OPEX USD 4.0 million to USD 5.6 million
• Year 2: 250 FTEs, OPEX USD 12 million to USD 17 million
• Year 3: 400 FTEs, OPEX USD 21 million to USD 30 million
• Equivalent bench at parent in Basel, Cambridge MA, Princeton, London, Tokyo: USD 95 million to USD 145 million
• Annual cost arbitrage at steady state: USD 70 million to USD 120 million
• NPV over 7 years at 12 per cent discount rate: USD 290 million to USD 510 million

14. Common Pitfalls

• Choosing Kharadi for a 500 plus FTE PV CoE when Hinjawadi or Talegaon are more cost-optimised
• Underestimating GxP and CSV setup time, plan 90 to 120 days
• Skipping the PV Physician hire in the first 6 months for ICSR medical review
• Not budgeting for validated Argus / ARISg / Veeva Vault Safety environments

15. Frequently Asked Questions

• Pune or Hyderabad for first Life Sciences GCC? Pune for PV, CDM, biostats, medical writing scale; Hyderabad if clinical research / bulk drug / vaccines is in scope
• Can the Pune GCC own global PV end to end? Yes, including ICSR, aggregate reports, signal detection, RMP and literature monitoring
• Realistic arbitrage versus Basel, Cambridge MA, Princeton, London, Tokyo? 70 to 80 per cent fully loaded
• BOT or Direct? BOT for first-time entrants below USD 5 billion revenue, Direct for established India operators

16. References and Further Reading

• NASSCOM, India GCC Landscape: nasscom.in/knowledge-center
• India Brand Equity Foundation (IBEF): www.ibef.org
• Reserve Bank of India (RBI): www.rbi.org.in
• Ministry of Corporate Affairs (MCA): www.mca.gov.in
• Central Board of Direct Taxes (CBDT): incometaxindia.gov.in
• Ministry of Electronics and Information Technology (MeitY): www.meity.gov.in
• Department for Promotion of Industry and Internal Trade (DPIIT): dpiit.gov.in
• OECD Inclusive Framework on BEPS: www.oecd.org/tax/beps
• World Economic Forum (WEF): www.weforum.org
• International Monetary Fund (IMF): www.imf.org
• Central Drugs Standard Control Organisation (CDSCO): cdsco.gov.in
• Indian Council of Medical Research (ICMR): www.icmr.gov.in
• ICH Guidelines (E2E, E6, E9, GVP): www.ich.org
• International Society of Pharmacovigilance (ISoP): isoponline.org
• Drug Information Association (DIA): www.diaglobal.org
• Bharati Vidyapeeth College of Pharmacy: bvuniversity.edu.in
• Savitribai Phule Pune University (SPPU): www.unipune.ac.in
• Maharashtra IT and ITES Policy: www.maharashtra.gov.in

Closing read

Pune is the global capital of Pharmacovigilance and Clinical Data Management Global Capability Centres. For scaled PV, CDM, biostats, programming and medical writing CoEs, Pune is the marginal-best city in the world. ChirayuGCC is the Integrated Partner. Jai Shri Krishna.